Prevalence of thrombotic polymorphisms in the healthy population in Southern Spain [2];Prevalencia de los polimorfismos genéticos asociados a trombofilia en población sana del Sur de España

Medicina Clinica

Volumn 122, Issue 14, 2004, Pages 556-557

  Gutiérrez Tous, María R ^a   Couto Caro, María C ^a   Garcia Donas Gabaldon G ^a   Pilo, I Simón ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LETTER; NORMAL HUMAN; PHENOTYPE; RISK FACTOR; SPAIN; THROMBOSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; GENETICS; MALE; MIDDLE AGED; PREVALENCE; THROMBOPHILIA;

ADULT; AGED; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; SPAIN; THROMBOPHILIA;

EID: 3343012321     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13060476     Document Type: Letter

References (11)

1. Simioni P. The molecular genetics of familiar venous thrombosis. Baillier's Clinical Haematology 1999;12:479-503.
2. Bertina RM. Genetic approach to thrombophilia. Thromb Haemost 2001;86:92-103.
3. Varela ML, Adamczuk YP, Forastiero RR, Martinuzzo ME, Cerrato GS, Pombo G, et al. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res 2001;104:317-24.
4. González Ordóñez AJ, Medina Rodríguez JM, Fernández Alvarez C, Sánchez García J, Fernández Carreira JM, Álvarez Martínez MV, et al. Reducción de concentraciones elevadas de homocisteína con ácido fólico y vitaminas B en pacientes con tromboembolia venosa: relación entre respuesta y genotipo C677T de la metilén tetrahidrofólico reductasa (MTHFR). Med Clin (Barc) 2000;114:7-12.
5. Reitsma PH. Genetic heterogeneity in hereditary thrombophilia. Haemostasis 2000;30(Suppl 2): 1-10.
6. Hilberg T, Jeschke D, Gabriel H. Hereditary thrombophilia in elite athletes. Med Sci Sports Exerc 2002;34:218-21.
7. Stefano V, Rossi E, Pacaroni K, Leone G. Screening for inherited thrombophilia: Indications and therapeutic implications. Haematologica 2002;87:1095-108.
8. Guillén M, Corella D, Portoles O, González JI, Mulet F, Saiz C. Prevalence of the methylenetetrahydrofolate reductase 677C> T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factor. Eur J Epidemiol 2001;17:255-61.
9. Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr 2001;4:493-7.
10. Madonna P, De Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-6.
11. Dilley A, Hooper WC, El-Jamil M, Renshaw M, Wengwe NK, Evatt BL. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR c → T677) and cystathione beta-synthase (CBS G → A919, CBS T ↑ c833) are not associated with myocradial infarction in African Americans. Thromb Res 2001;103:109-15.